Optimization of Erythrocyte Lysis Protocols for Robust and Reproducible T Cell Analysis in Murine Peripheral Blood, Spleen, Lung, and Bone Marrow
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/3335332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 07.04.2026. Verfasst von Wei-Qian Bao und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China, gzucm.edu.cn. Hauptthemen laut MEDLINE: Erythrocytes, Spleen, Flow Cytometry, Lung. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Major Project of Guangzhou National Laboratory.
Abstract (Originalsprache)
Flow cytometry analysis of T lymphocytes in murine peripheral blood, spleen, lung, and bone marrow is critical for immune studies. However, inconsistent erythrocyte lysis remains a major challenge—incomplete lysis obscures lymphocyte detection, while excessive lysis damages T cells. Moreover, the variable performance of commercial lysis buffers across tissues and protocols complicates reproducibility. To address these challenges, we first established a lysis buffer that provides a relatively balanced effect on erythrocyte lysis and lymphocyte protection by systematically comparing BD, BioLegend, and Biosharp buffers in murine peripheral blood. Given the high content of red blood cells (RBCs) in peripheral blood, we used it as a screening model to identify a buffer that effectively lysed RBCs while maintaining lymphocyte integrity. The BD lysing solution demonstrated superior performance, achieving effective erythrocyte removal with 41.40% CD3 + cell of the lymphocyte population at 1‐min lysis (compared to BioLegend: 38.70% and Biosharp: 36.90% at their recommended durations). This buffer was then used as the unified buffer for subsequent multitissue optimization, ensuring a balanced effect across different tissue types. Building on this foundation, we developed a standardized framework, which resolves tissue‐specific barriers. Spleen: Balanced erythrocyte clearance was achieved using 150 μL/million cells, yielding 67.23% ± 8.21% CD3 + lymphocytes. CD4 + and CD8 + T cell subsets constituted 58.50% ± 0.85% and 36.63% ± 0.85% of CD3 + cells, respectively (CD4/CD8 ratio: 1.60 ± 0.60). Lung: Adaptive processing volumes (30–150 μL/million cells) accommodated variable dissociation yields (1–5 × 10 6 cells/sample). CD45 + cells represented 42.87% ± 6.05% of live cells, with CD3 + cells dominating the lymphocyte compartment (96.57% ± 1.35%). CD4 + (58.50% ± 1.44%) and CD8 + (39.23 ± 1.12%) T cell proportions mirrored splenic distribution. Bone marrow: Erythrocyte depletion at 33.3 μL/million cells preserved rare lymphocytes (6.53% ± 0.30% of total cells). CD3 + cells comprised 21.80% ± 3.26% of CD45 + lymphocytes, exhibiting distinct subset ratios (CD4 + : 57.34% ± 4.60%; CD8 + : 50.50% ± 2.78%). Collectively, these protocols enable robust, operator‐independent T cell analysis across murine immune compartments, providing a universal standard for translational immunology studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510006, Guangdong, China, gzucm.edu.cn.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China, sysucc.org.cn.
- Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518000, Guangdong, China, szszyy.cn.
- Department of Drug and Vaccine Research, Guangzhou Laboratory, Guangzhou, 510005, Guangdong, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, 510006, Guangdong…
- Traditional Chinese Medicine Immune Metabolism and Microecology Technology Development Platform, Chinese Medicine Guangdong Laboratory, Zhuhai, 519031, Guangdong, China.
ORCID-Profile: Wei-Qian Bao, Meng-Lin Jiang, Nan-Jie Zhou, Li-Rong Lian, Shu-Qin Li, Bi-Qing Huang, Tu-Liang Liang, Gang-Yuan Ma, Cui-Fen Zhang, Ying Chen, Xiao Shu, Liang Liu, Hu-Dan Pan, Run-Ze Li
Förderung
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Major Project of Guangzhou National Laboratory
- Natural Science Foundation of Guangdong Province
- "Pearl River Talent Plan" Innovation and Entrepreneurship Team Introduction Projects of Guangdong Province
- Traditional Chinese Medicine Bureau of Guangdong Province
- State Key Laboratory of Traditional Chinese Medicine Syndrome
- Chinese Medicine Guangdong Laboratory
Zitieren
APA
Bao, W. Q., Jiang, M. L., Zhou, N. J., Lian, L. R., Li, S. Q., Huang, B. Q., Liang, T. L., Ma, G. Y., Zhang, C. F., Chen, Y., Shu, X., Liu, L., Pan, H. D., & Li, R. Z. (2026). Optimization of Erythrocyte Lysis Protocols for Robust and Reproducible T Cell Analysis in Murine Peripheral Blood, Spleen, Lung, and Bone Marrow. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/3335332
Vancouver
Bao WQ, Jiang ML, Zhou NJ, Lian LR, Li SQ, Huang BQ, et al. Optimization of Erythrocyte Lysis Protocols for Robust and Reproducible T Cell Analysis in Murine Peripheral Blood, Spleen, Lung, and Bone Marrow. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/3335332
BibTeX
@article{Bao2026,
author = {Bao, Wei-Qian and Jiang, Meng-Lin and Zhou, Nan-Jie and Lian, Li-Rong and Li, Shu-Qin and Huang, Bi-Qing and Liang, Tu-Liang and Ma, Gang-Yuan and Zhang, Cui-Fen and Chen, Ying and Shu, Xiao and Liu, Liang and Pan, Hu-Dan and Li, Run-Ze},
title = {Optimization of Erythrocyte Lysis Protocols for Robust and Reproducible T Cell Analysis in Murine Peripheral Blood, Spleen, Lung, and Bone Marrow},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/3335332}
}
EUVIMED